With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.

Molecular studies may point to underlying genetics and therapeutic targets.

Recombinase polymerase amplification lets researchers rapidly replicate DNA in the clinic, in the field, or even in the International Space Station.

At The Scientist, we are strengthening our roots while reaching for the sky.

To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.

Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.

Researchers leave no stone unturned in the search for a spinal muscular atrophy treatment strategy that uses base editing.